85 related articles for article (PubMed ID: 143125)
1. [Role of mass screening in detection of ovarian tumors].
Nikolaeva DV
Vopr Onkol; 1977; 23(3):68-74. PubMed ID: 143125
[TBL] [Abstract][Full Text] [Related]
2. [Value of dispensary examination for the earliest possible detection of malignant ovarian tumors].
Loskutova GP; Vesnin AG
Vopr Onkol; 1977; 23(3):75-8. PubMed ID: 143126
[TBL] [Abstract][Full Text] [Related]
3. [Potential for improving the early diagnosis of malignant ovarian tumors].
Nikolaeva DV
Vopr Onkol; 1980; 26(12):75-80. PubMed ID: 6451079
[TBL] [Abstract][Full Text] [Related]
4. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
5. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of the complex diagnosis of ovarian tumors].
Loskutova GP
Vopr Onkol; 1978; 24(3):50-4. PubMed ID: 148161
[TBL] [Abstract][Full Text] [Related]
7. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
[TBL] [Abstract][Full Text] [Related]
8. Characteristics relating to ovarian cancer risk: implications for prevention and detection.
Whittemore AS
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800
[TBL] [Abstract][Full Text] [Related]
9. [Screening for ovarian cancers: critical analysis].
Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
[TBL] [Abstract][Full Text] [Related]
10. [The prophylactic oophorectomy. An unsolved problem].
Salvatores M; Mage G; Wattiez A
Minerva Ginecol; 2007 Oct; 59(5):549-52. PubMed ID: 17912181
[TBL] [Abstract][Full Text] [Related]
11. [Hormonally-active ovarian tumors in 30 years of data (1965-1994)].
Molnar E; Sloboda L; Fenjvesi A; Zivković S
Med Pregl; 1999; 52(6-8):241-5. PubMed ID: 10518380
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and screening of ovarian cancer.
Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
[TBL] [Abstract][Full Text] [Related]
13. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. Relative frequency of primary ovarian neoplasms: a 10-year review.
Koonings PP; Campbell K; Mishell DR; Grimes DA
Obstet Gynecol; 1989 Dec; 74(6):921-6. PubMed ID: 2685680
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
17. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
18. [Early detection and preoperative diagnosis of ovarian carcinoma].
Kainz C
Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer screening: a primary care guide.
Thompson SD
Lippincotts Prim Care Pract; 1998; 2(3):244-50. PubMed ID: 9644439
[TBL] [Abstract][Full Text] [Related]
20. Prospectively detected cancer in familial breast/ovarian cancer screening.
Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
